Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from December 26 through December 30 include:
- Beneficial Owner of ChargePoint (CHPT) Q-GRG VII purchased 1,436,377 shares of company stock at $8.28 per share for a total transaction amount of $11,899,234
- Director of Terns Pharmaceuticals (TERN) Carl Gordon purchased 137,931 shares of company stock at $7.25 per share for a total transaction amount of $1,000,000
- Officer of GlycoMimetics (GLYC) Edwin Rock purchased 110,000 shares of company stock at $2.25 per share for a total transaction amount of $247,500
- CFO of Athira Pharma (ATHA) Glenna Mileson purchased 50,000 shares of company stock at $2.85 per share for a total transaction amount of $142,250
NOTABLE INSIDER SALES: Significant insider sales in the prior week from December 26 through December 30 include:
- CEO of AES Corporation (AES) Andres Gluski sold 748,625 shares of company stock at $28.43 per share for a total transaction amount of $21,283,409
- Officer of Clean Harbors (CLH) Robert Speights sold 2,826 shares of company stock at $113.71 per share for a total transaction amount of $378,313
- VP of Best Buy (BBY) Damien Harmon sold 2,500 shares of company stock at $79.99 per share for a total transaction amount of $199,975
- Chairman of BeiGene (BGNE) John Oyler sold 9,609 shares of company stock at $224.43 for a total transaction amount of $2,156,571
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Terns Pharmaceuticals jumped over 40% after Director Carl Gordon purchased 137,931 shares of company stock at $7.25 per share, while shares of Best Buy fell almost 2% after VP Damien Harmon sold 2,500 shares of company stock at $79.99 per share.
